Ignore the PR fluff from Lemming, but the reality is we have a crap CEO, who has no support but is still in post. ? The largest shareholders will sell and move on.
RE: THIS SPEAKS VOLUME.. DIRECTORS SELL17 Mar 2024 10:56
Why would it be unusual for the Scientific Officer not to make a comment on the new product line. I hold Prof. O'Neill in high esteem, but not with the vastly overpaid BoD's.
So is 13% interest for a loss making mine which even Avani realise that their investment will not make a profit and the ability of Ben to pay the interest on the loans is impossible.
Elric, please explain how I have misinterpreted you. My gripe is with the current board of Skinbio and their unforgivable stupidity. Whatever you are insinuating I am at a total loss.
In reply to TW's email, Stuart Ashman stated categorically that no introductory fee was paid, either to board members or advisors. This huge financing mistake that the BoD's have inflicted on the company warrants that the board take a salary cut. This gesture would certainly benefit the company and placate investor sentiment.